Beam Therapeutics Inc.
BEAM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001745999
In the last 90 days, Beam Therapeutics Inc. insiders filed 0 open-market purchases and 1 sale; 277 institutions reported holding it in 13F filings for Q2 2026, worth $3.75B in total; superinvestors ARK Invest and Duquesne Family Office hold it.
Q4 2024 vs. Q3 2024
How the institutions holding Beam Therapeutics Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 221 | 3 | 232 | +14 |
| Shares | 79.0M | 22.5K | 81.5M | +2.43M (+3.1%) |
| Value | $1.94B | $537.2K | $2.02B | +$83.0M (+4.3%) |
3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (37)
Institutions that held Beam Therapeutics Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (23)
Institutions that held Beam Therapeutics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Logos Global Management LP | 500,000 | $12.3M |
| Susquehanna Portfolio Strategies, LLC | 126,710 | $3.10M |
| International Assets Investment Management, LLC | 64,313 | $2.63M |
| Bank of Montreal | 45,045 | $1.13M |
| XTX Topco Ltd | 37,001 | $906.5K |
| Capital Fund Management S.A. | 31,025 | $760.1K |
| DnB Asset Management AS | 20,799 | $509.6K |
| Steel Peak Wealth Management LLC | 17,355 | $425.2K |
| Prudential Financial Inc | 14,089 | $345.2K |
| Teza Capital Management LLC | 12,285 | $301.0K |
| E Fund Management Co., Ltd. | 12,020 | $294.5K |
| Krilogy Financial LLC | 10,933 | $267.9K |
| Hemenway Trust Co LLC | 10,755 | $263.5K |
| Corton Capital Inc. | 9,917 | $243.0K |
| Vident Advisory, LLC | 9,190 | $225.2K |
| AQR Capital Management LLC | 8,842 | $216.6K |
| Arcadia Investment Management Corp | 4,000 | $98.0K |
| Golden State Equity Partners | 260 | $6.37K |
| Meeder Asset Management Inc | 118 | $2.89K |
| Liberty One Investment Management, LLC | 87 | $2.13K |
| AdvisorNet Financial, Inc | 45 | $1.10K |
| Bessemer Group Inc | 35 | $1.00K |
| Northwestern Mutual Wealth Management Co | 24 | $588 |
Not filed for Q4 2024 yet (3)
Institutions that held Beam Therapeutics Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| ClariVest Asset Management LLC | 12,816 | $300.3K |
| Raymond James Financial Services Advisors, Inc. | 9,485 | $232.4K |
| Abich Financial Wealth Management LLC | 187 | $4.58K |